173 related articles for article (PubMed ID: 10686275)
1. Improved assay for fecal calprotectin.
Tøn H; Brandsnes ; Dale S; Holtlund J; Skuibina E; Schjønsby H; Johne B
Clin Chim Acta; 2000 Feb; 292(1-2):41-54. PubMed ID: 10686275
[TBL] [Abstract][Full Text] [Related]
2. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P
Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517
[TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease.
Bunn SK; Bisset WM; Main MJ; Golden BE
J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):171-7. PubMed ID: 11321388
[TBL] [Abstract][Full Text] [Related]
4. Fecal excretion of calprotectin in colorectal cancer: relationship to tumor characteristics.
Kristinsson J; Armbruster CH; Ugstad M; Kriwanek S; Nygaard K; Tøn H; Fuglerud P
Scand J Gastroenterol; 2001 Feb; 36(2):202-7. PubMed ID: 11252414
[TBL] [Abstract][Full Text] [Related]
5. Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm.
Husebye E; Tøn H; Johne B
Am J Gastroenterol; 2001 Sep; 96(9):2683-7. PubMed ID: 11569695
[TBL] [Abstract][Full Text] [Related]
6. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease.
Bunn SK; Bisset WM; Main MJ; Gray ES; Olson S; Golden BE
J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):14-22. PubMed ID: 11479402
[TBL] [Abstract][Full Text] [Related]
7. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy.
Limburg PJ; Ahlquist DA; Sandborn WJ; Mahoney DW; Devens ME; Harrington JJ; Zinsmeister AR
Am J Gastroenterol; 2000 Oct; 95(10):2831-7. PubMed ID: 11051356
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent variations in fecal calprotectin concentrations in children.
Rugtveit J; Fagerhol MK
J Pediatr Gastroenterol Nutr; 2002 Mar; 34(3):323-4; author reply 324-5. PubMed ID: 11964964
[No Abstract] [Full Text] [Related]
9. Assessment of ileal pouch inflammation by single-stool calprotectin assay.
Thomas P; Rihani H; Røseth A; Sigthorsson G; Price A; Nicholls RJ; Bjarnason I
Dis Colon Rectum; 2000 Feb; 43(2):214-20. PubMed ID: 10696896
[TBL] [Abstract][Full Text] [Related]
10. Screening of first degree relatives of patients operated for colorectal cancer: evaluation of fecal calprotectin vs. hemoccult II.
Kristinsson J; Nygaard K; Aadland E; Barstad S; Sauar J; Hofstad B; Stray N; Stallemo A; Haug B; Ugstad M; Tøn H; Fuglerud P
Digestion; 2001; 64(2):104-10. PubMed ID: 11684824
[TBL] [Abstract][Full Text] [Related]
11. Fecal marker variability in colorectal cancer: calprotectin versus hemoglobin.
Gilbert JA; Ahlquist DA; Mahoney DW; Zinsmeister AR; Rubin J; Ellefson RD
Scand J Gastroenterol; 1996 Oct; 31(10):1001-5. PubMed ID: 8898421
[TBL] [Abstract][Full Text] [Related]
12. Fecal calprotectin levels in healthy children studied with an improved assay.
Fagerberg UL; Lööf L; Merzoug RD; Hansson LO; Finkel Y
J Pediatr Gastroenterol Nutr; 2003 Oct; 37(4):468-72. PubMed ID: 14508218
[TBL] [Abstract][Full Text] [Related]
13. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children.
Olafsdottir E; Aksnes L; Fluge G; Berstad A
Acta Paediatr; 2002; 91(1):45-50. PubMed ID: 11883817
[TBL] [Abstract][Full Text] [Related]
14. Reference Intervals for Fecal Calprotectin in Adults Using Two Different Extraction Methods in the Uppsala-SCAPIS Cohort.
Fall T; Mandic-Havelka A; Helmersson-Karlqvist J; Sundstrom J; Larsson A
Clin Lab; 2017 Sep; 63(9):1493-1496. PubMed ID: 28879709
[TBL] [Abstract][Full Text] [Related]
15. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma.
Tibble J; Sigthorsson G; Foster R; Sherwood R; Fagerhol M; Bjarnason I
Gut; 2001 Sep; 49(3):402-8. PubMed ID: 11511563
[TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin concentration in patients with colorectal carcinoma.
Kristinsson J; Røseth A; Fagerhol MK; Aadland E; Schjønsby H; Børmer OP; Raknerud N; Nygaard K
Dis Colon Rectum; 1998 Mar; 41(3):316-21. PubMed ID: 9514426
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study.
Røseth AG; Fagerhol MK; Aadland E; Schjønsby H
Scand J Gastroenterol; 1992 Sep; 27(9):793-8. PubMed ID: 1411288
[TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin: a significant step in the noninvasive assessment of intestinal inflammation.
Bjarnason I; Sherwood R
J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):11-3. PubMed ID: 11479401
[No Abstract] [Full Text] [Related]
19. Role of fecal calprotectin in the assessment of intestinal inflammation in children with familial Mediterranean fever.
Gucenmez OA; Kume T; Makay B; Babayigit O; Arslan N; Unsal E
Int J Rheum Dis; 2018 Oct; 21(10):1844-1848. PubMed ID: 30345692
[TBL] [Abstract][Full Text] [Related]
20. Faecal calprotectin levels and colorectal neoplasia.
Brydon WG; Campbell SS; Anderson NA; Wilson RG; Ghosh S
Gut; 2001 Apr; 48(4):579-80. PubMed ID: 11288736
[No Abstract] [Full Text] [Related]
[Next] [New Search]